Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytes.

Adam W Feinberg1, Crystal M Ripplinger, Peter van der Meer

  • 1Disease Biophysics Group, School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA ; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA ; Wyss Institute of Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA.

Stem Cell Reports
|November 29, 2013
PubMed
Summary

Engineered cardiac tissues from stem cell-derived cardiomyocytes show different electromechanical properties compared to neonatal tissues. This highlights the need for specific performance metrics for stem cell therapies in regenerative medicine.

Related Concept Videos